| Level I | Good quality evidence |
Systematic review of RCTs with consistent findings High quality individual RCT |
| Level II |
Limited quality patient orientated evidence |
Systematic review of lower quality studies or studies with inconsistent findings Low quality clinical trial Cohort studies Case-control studies |
| Level III | Other |
Consensus guidelines, extrapolations from bench research, usual practice, opinion, disease-oriented evidence (intermediate or physiologic outcomes only), or case series |
[28] Antiretroviral medicines dosing and common adverse drug reactions: National Department of Health, Essential Drugs Programme: Adult Hospital Level STGs and EML, 2019. http://www.health.gov.za/
Antiretroviral medicines dosing and common adverse drug reactions: National Department of Health. 2019 ART Clinical Guidelines for the Management of HIV in Adults, Pregnancy, Adolescents, Children, Infants and Neonates. https://www.knowledgehub.org.za/elibrary/2019-art-clinical-guidelines-management-hiv-adults-pregnancy-adolescents-children-infants
Antiretroviral medicines dosing and common adverse drug reactions: Meintjes G, Moorhouse MA, Carmona S, Davies N, Dlamini S, van Vuuren C, Manzini T, Mathe M, Moosa Y, Nash J, Nel J, Pakade Y, Woods J, Van Zyl G, Conradie F, Venter F. Adult antiretroviral therapy guidelines 2017. South Afr J HIV Med. 2017 Jul 15;18(1):776. https://www.ncbi.nlm.nih.gov/pubmed/29568644
Antiretroviral medicines dosing and common adverse drug reactions: South African Medicines Formulary. 12th Edition. Division of Clinical Pharmacology. University of Cape Town, 2016.
Antiretroviral medicines dosing and common adverse drug reactions: Datapharm Ltd. Electronic medicines compendium (emc). [Internet][Accessed 28 November 2019] https://www.medicines.org.uk/emc/